What are the benefits of using aflibercept with a proactive, T&E approach in AMD? Two experts sp

LEARN MORE

Expert comments on the 6-month results of the APOLLON study, investigating the real-world outcomes o

LEARN MORE

Two-year follow-up of real world outcomes of intravitreal aflibercept

LEARN MORE

Marc De Smet, MD, PhD. The importance of biomarkers for the treatment of individual patients

LEARN MORE
Older »

Error